University of Ioannina
Η αποτελεσματικότητα του συνδυασμού προπαφαινόνης και ιμπουτιλίδης στην ανάταξη της κολπικής μαρμαρυγής πρόσφατης έναρξης
Abstract
dc:descriptionBackground: Pharmacological conversion of persistent atrial fibrillation (AF) is associated with modest success rates, but combined antiarrhythmic regiments have not been well studied. Objective: To assess the efficacy and safety of pharmacological conversion of persistent AF with a combined propafenone plus ibutilide regimen. Methods and results: One hundred consecutive patients (66 male, age 65±10 years) with persistent AF (mean duration 99±92 days) admitted for elective pharmacological cardioversion, were randomly assigned to either treatment with intravenous ibutilide (1 mg plus additional 1 mg, if required) (n =51) or oral propafenone (600 mg) plus intavenous ibutilide at the same dosage (n=49). Success rates were 41,1% (21 of 53 patients) for ibutilide alone and 71,4% (35 of 49 patients) for propafenone plus ibutilide (p=0,0044). However, cardioversion occurred earlier in the former group (55±20 min), compared to the latter group (81±32 min, p=0,0019). A comparable increase in the QTc interval was observed in both groups, but one case of sustained torsde de pointes, requiring electrical cardioversion was observed in the propafenone plus ibutilide group. No other complications were noted during the hospitalizations period. Conclusion: Concurrent administration of propafenone plus ibutilide for pharmacologic cardioversion of persistent AF is safe and significantly more effective compared to ibutilide alone.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Draganigos, Antonios
- Δραγανίγος, Αντώνιος-Φοίβος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20654